medical treatment

Major Bleed Risk Falls With Bivalirudin vs Heparin en Route to PCI for STEMI

Major Bleed Risk Falls with Bivalirudin vs Heparin en Route to PCI for STEMI

Filed under: drug treatment programs in san francisco

SAN FRANCISCO, CA (updated)— The 30-day risk of death or major bleeding fell significantly in ST-elevation MI (STEMI) patients treated with bivalirudin (Angiomax, the Medicines Company) compared with heparin-based management, both initiated prior to …
Read more on Medscape

 

BREO® ELLIPTA(TM) now available in the U.S. for the treatment of COPD

Filed under: drug treatment programs in san francisco

RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., Oct. 30, 2013 /PRNewswire via COMTEX/ — GlaxoSmithKline plc (lse/nyse:GSK) and Theravance, Inc. (NASDAQ:THRX) today announced that BREO ELLIPTA, a once-daily prescription medicine for …
Read more on MarketWatch

 

Editorial: Herrera for city attorney

Filed under: drug treatment programs in san francisco

With regard to City College of San Francisco, Herrera's office recently filed a lawsuit against the Accrediting Commission for Community and Junior Colleges, alleging that the private agency unlawfully allowed its advocacy and political bias to …
Read more on Bay Area Reporter

 

Five Prime Therapeutics Inc (FPRX): Five Prime: A Growing Oncology And

Filed under: drug treatment programs in san francisco

Once a rarely used subset of medical treatments, protein therapeutics have increased dramatically in number and frequency of use since the introduction of the first recombinant protein therapeutic – human insulin – 25 years ago. Protein therapeutics …
Read more on Seeking Alpha